The Cellex Rapid Test can detect antibodies against the SARS-CoV-2 virus.
The Food and Drug Administration (FDA) has approved the first test in the U.S. designed to detect coronavirus antibodies, according to a letter of authorization. Widespread antibody testing can be useful in determining how many people in a population were infected with the virus and might now be immune.
Up until now, all of the coronavirus tests conducted, were designed to find fragments of the virus itself. This type of test, which uses a method called PCR to find viral RNA in nasal samples, is useful for detecting people who are currently infected with the coronavirus or had virus in past and now have developed antibodies for it.This test can indicate past coronavirus infections by identifying immunoglobulin M and G antibodies in the blood that are produced by the body’s immune system to fight the disease.